Theravance Biopharma Inc (NASDAQ:TBPH) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a report released on Friday. TBPH has been the topic of a number of other research reports. Needham & Company LLC upped their target price on Theravance Biopharma from $40.00 to $45.00 and gave the […]
